Sydney, Australia, July 20, 2021 -- DePuy Synthes, the orthopaedics company of Johnson & Johnson, today announced that Australian orthopaedic surgeons will be among the first in the world to access the next generation of robotics. The VELYS™ Robotic-Assisted Solution, indicated for use with the ATTUNE® Knee System for total knee arthroplasty, has recently been included on the Australian Register of Therapeutic Goods (ARTG).
Sue Martin, Managing Director of Johnson & Johnson Medical Australia and New Zealand says: “Australia joins an exclusive list of just a few countries with access to this technology to date. The introduction of the VELYS Robotic-Assisted Solution is testament to Johnson & Johnson Medical Device’s ongoing commitment to create innovative technologies that help hospitals and surgeons improve patient outcomes and advance the sustainability of Australia’s healthcare system.”
An increasing number of surgical procedures utilise robotic assistance[iii]. However, the impact of robotic technology on operational efficiency, including surgical time and the technological learning curve, has been reported as a drawback.[iv]
The VELYS Robotic-Assisted Solution is designed to respond to this challenge as a first-of-its-kind operating table mounted solution that adapts to the surgeon’s workflow and utilises advanced planning capabilities, proprietary technology, and a next generation design to help surgeons accurately resect bones that align and position the implant relative to the soft-tissue during total knee replacement without the need for pre-operative imaging. The efficient and compact design integrates into any operating room and does so with a much smaller footprint, at less than half the size of some other robotic-assisted solutions.i,ii
The VELYS Robotic-Assisted Solution simplifies knee replacement surgery by providing:
- Valuable Insights: Gap balance data to help surgeons visualise and predict joint stability
- Versatile Execution: Instinctive, integrated design to give surgeons the control they’re used to while optimising daily OR flow[v]
- Verified Performance: Accurate, consistent plan execution supporting the ATTUNE Knee in providing better patient outcomes[vi],[vii],[viii],[ix]
Dr Mark Clatworthy, an orthopaedic knee surgeon based in Auckland, New Zealand, who last year became the first surgeon in the world to perform surgery using this technology says: “I’ve used the VELYS Robotic-Assisted Solution in 60 of my ATTUNE Knee procedures and have found it to be accurate, fast and efficient.”
“This next generation device enables me to evaluate the bony anatomy and soft tissue envelope of the knee to plan the optimal implant position and then use the robotic-assisted solution to deliver and execute the plan. I’ve found my knees to be well balanced at the end of the procedure and my patients are doing well post-operatively.[x]”
The VELYS Robotic-Assisted Solution is part of the broader VELYS Digital Surgery Platform of connected technologies powered by data insights and designed to elevate the orthopaedic experience for patients, surgeons, and their teams across the entire continuum of care, from pre-operative to post-operative.
Ben Travers, Vice President of DePuy Synthes in Australia explains: “VELYS Robotic-Assisted Solution works exclusively with the ATTUNE Knee System, which studies have shown can improve clinical outcomes and patient-reported outcomes, as well as contribute to a shorter length of stay in hospital.[xi],viii,ix,[xii] Supporting the ‘patient specific alignment’ surgical method, VELYS Robotic-Assisted Solution has also been designed to assist surgeons in providing a knee alignment that is tailored to each patient’s anatomy.
“With the addition of VELYS Robotic-Assisted Solution to our VELYS Digital Surgery Platform, we are continuing our vision to be the most personalised and connected orthopaedics company,” he adds.
Next generation training for a next generation robotics solution
To ensure surgeons and hospitals are supported in introducing VELYS Robotic-Assisted Solution, DePuy Synthes Australia is providing a suite of training solutions to enable surgeons and their teams to test and familiarise themselves with the technology and how it operates.
“To support a next generation robotic solution, we’ve made a significant investment in next generation training to provide comprehensive, accessible, and personalised learning to the VELYS Robotic-Assisted Solution,” says Travers.
Training solutions will include:
- a semi-trailer mounted mobile lab with self-contained meeting, training, and lab space with VELYS Robotic-Assisted Solution; this mobile training environment is enabled to connect with surgeons and R&D teams around the world;
- life-like, 3D printed, surgical models for an enhanced surgical training experience;
- virtual reality operating environments where surgeons around the world can experience virtual reality surgical procedures using VELYS Robotic-Assisted Solution, and;
- a dedicated and personalised online learning platform.
“Our high-tech mobile lab is the first of its kind in Australia. We’ll bring it to hospitals and clinical teams to facilitate hands-on learning, without the need for them to travel to undertake lab-based training,” Travers added.
The mobile lab will begin its tour, visiting hospitals throughout Australia, in September 2021.
For more information on VELYS Robotic-Assisted Solution healthcare professionals can visit: www.velysdigitalsurgery.com/au
###
About DePuy Synthes:
DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit www.jnjmedicaldevices.com/en-au/companies/depuy-synthes .
About Johnson & Johnson Medical Devices Companies:
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.
[i] RIO Technical User Guide (February 24, 2021). Internal Report 103732371. (As cited in The VELYS™ Robotic-Assisted Solution versus Mako® A comparison of system compactness)
[ii] VELYS Robotic-Assisted Solution Operation Dimension (February 24, 2021). Internal Report 103486302. (As cited in The VELYS™ Robotic-Assisted Solution versus Mako® A comparison of system compactness)
[iii] Millennium Research Group, Inc. Orthopaedic Surgical Robotic Devices. 2018; M360SU0001
[iv] P Sousa et. al. 2020. Robots in the operating room during hip and knee arthroplasty. Curr Rev Musculoskelet Med. Accessed: 8 July 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251009/
[v] ser experience evaluation of the VELYS Robotic-Assisted Solution for total knee (July 2020). Internal Report 103744839.
[vi] Doan G, Curtis P, Wyss J, Clary C. Resection Accuracy Improved during Robotic-Assisted Total Knee Arthroplasty – a Cadaveric Study. Internal Report 103720852.
[vii] Hamilton W, Brenkel I, Barnett S, et al. Comparison of P.F.C. SIGMA to ATTUNE: A Prospective, Multicenter Study. Podium Presentation at the Closed Meeting of the Knee Society, Sept 2018, St Louis, MO, USA. 2018.
[viii] Fisher D, Parkin D. Optimizing the Value of Your Patients’ TKA: How to Leverage Data from Patient Reported Outcomes, Becker’s Hospital Review, webinar recording, Oct 2019, www.ATTUNEevidence.com/clinical-evidence, last accessed 10-18-19.
[ix] Ranawat CS, White PB, West S, Ranawat AS. Clinical and Radiographic Results of ATTUNE and PFC SIGMA Knee Designs at 2-Year Follow-Up: A Prospective Matched-Pair Analysis. J Arthroplasty 2017; 32:431-6.
[x] Dr. Mark Clatworthy is a surgeon innovator for DePuy Synthes Joint Reconstruction.
Media Contact:
David Sims
Johnson & Johnson Medical Australia & New Zealand
M: +61 (0)409 928 209
E: dsims5@its.jnj.com